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Abstract
Androgens regulate prostate physiology, and exert their effects through the androgen receptor. We hypothesized that
androgen deprivation needs additional transcription factors to orchestrate the changes taking place in the gland after
castration and for the adaptation of the epithelial cells to the androgen-deprived environment, ultimately contributing to
the origin of castration-resistant prostate cancer. This study was undertaken to identify transcription factors that regulate
gene expression after androgen deprivation by castration (Cas). For the sake of comparison, we extended the analysis to the
effects of administration of a high dose of 17b-estradiol (E2) and a combination of both (Cas+E2). We approached this by (i)
identifying gene expression profiles and enrichment terms, and by searching for transcription factors in the derived
regulatory pathways; and (ii) by determining the density of putative transcription factor binding sites in the proximal
promoter of the 10 most up- or down-regulated genes in each experimental group in comparison to the controls Gapdh
and Tbp7. Filtering and validation confirmed the expression and localized EVI1 (Mecom), NFY, ELK1, GATA2, MYBL1, MYBL2,
and NFkB family members (NFkB1, NFkB2, REL, RELA and RELB) in the epithelial and/or stromal cells. These transcription
factors represent major regulators of epithelial cell survival and immaturity as well as an adaptation of the gland as an
immune barrier in the absence of functional stimulation by androgens. Elk1 was expressed in smooth muscle cells and was
up-regulated after day 4. Evi1 and Nfy genes are expressed in both epithelium and stroma, but were apparently not affected
by androgen deprivation.
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Introduction
Androgens are required for prostate development, growth and
physiology, by activating the androgen receptor (AR), which is
expressed in both epithelial and stromal cells of the adult prostate
gland [1,2]. More than 300 proteins have been identified to
contribute to AR activation and to modulate its transcription
activity [3–6], to promote a variety of gene expression patterns in
cells and tissues [7].
Understanding the mechanisms of androgen regulation in the
prostate gland is important, because the prostate is affected by
several different diseases, in particular prostate cancer (PCa).
Several ways exist to treat prostate cancer and promote cell cycle
arrest and/or epithelial cell death. Treatments involving androgen
manipulation include surgical castration (bilateral orchiectomy),
antiandrogens (usually AR antagonists), or substances that inhibit
androgen synthesis (5a-reductase inhibitors, gonadotrophin-re-
leasing hormone blockers) [8]. 17b-estradiol exerts anti-androgen
effects by blocking the hypothalamic production of gonadotropin-
releasing hormone and thereby inhibiting the production of
testosterone by the testes [9], but also acts locally via interactions
with either of the estrogen receptors found in the gland.
The two major drawbacks to the use of antiandrogens or
androgen deprivation therapies are the systemic side effects,
including physiological (bone loss, muscle weakness, temperature
deregulation, cardiovascular problems) and behavioral changes
(loss of stamina, apathy, loss of libido and depression) on the one
hand, and progression to castration-resistant prostate cancer
(CRPC), which is more aggressive than the original disease, on
the other.
Although androgens are highly important for prostate cancer
development, after androgen deprivation the disease progresses to
a castration-resistant state that may be driven by AR mutations,
amplifications and/or ligand-independent activation, which can
keep the prostate epithelial cells alive in an androgen-poor
environment [10,11]. In addition to the mechanisms centered on
AR expression and functioning, a variety of chromosomal and
physiological changes are associated with PCa progression (i.e.
tumor growth, metastasis and androgen independence) [12], and
chromosome aberrations, including frequent bridging (chromo-
plexy) [13].
Previous analyses of gene expression revealed significant aspects
of prostate physiology [14–19]. These studies employed different
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strategies to obtain the data, and arrived at different subsets of
genes that are differentially expressed in response to challenging
hormonal conditions. Given the extreme drop in secretory
function in response to androgen, and the complex interactions
between the epithelium and the stroma, it is possible that subtle
changes in physiologically important factors are obscured in the
mass of information obtained. For instance, Desai et al. (2004)
pointed out a progressive increase in PTEN expression in the
epithelial cells and several genes grouped together to characterize
an ‘‘immune-inflammatory’’ response, which was validated and
correlated with a high concentration of immune-system cells
including macrophages, mast cells and lymphocytes [15]. The
concentration of these cells is another complicating component in
the analyses of gene expression, because they contribute their own
mRNA. Asivartham et al. (2006) worked with isolated cells in
primary cultures, but in these conditions, the contribution of
mutual stromal-epithelial interactions is absent [19].
We therefore hypothesized that a better understanding of the
nature of the cells that survive castration would benefit the search
for strategies to allow a blockade or at least an extension of the
time needed for the transition to the CRPC, and that the
identification of regulatory networks for transcription factors (TF)
could reveal new therapeutic targets.
Pursuing the idea that additional TF could be co-opted for
coordinating gene expression that would contribute not only to
epithelial-cell death but also to an adaptation of the organ in
general and the epithelium in particular to varying hormonal
conditions, notably complete androgen deprivation, and that these
changes increase the susceptibility to progression to CRPC, we
performed gene expression profiling using DNA microarrays to
identify TF associated with the most-regulated genes after
androgen deprivation by surgical castration (Cas group). We
included in the analyses a group of rats that received a high dose of
17b-estradiol (E2 group) (falling androgen level and high estrogen)
and a group of rats that were castrated and treated with E2 (Cas+
E2 group; low androgen, high estrogen).
Inspired by the study of Yeh et al. (2009), we attempted to
identify regulatory networks among the genes obtained from
microarray data, by examining the relatedness between the
regulated genes and structural signatures in their promoters
[20]. In a first approach, we identified all genes showing
differential expression in each experimental group when compared
to the controls. The differentially expressed genes were arranged
into enrichment terms, and the resulting regulatory gene networks
constructed were used for the identification of candidate TF. In a
second approach, we examined the 3,000 bp proximal promoter
of the ten most differentially expressed genes for the presence of
putative transcription-factor binding sites, and determined their
relative abundance with respect to the corresponding promoter
regions of two internal control genes (i.e. not regulated by each
treatment). The filtered TF were then validated by qRT-PCR and
localized in the gland by immunohistochemistry. The expression
pattern and tissue location of these TF appear to be important for




Forty-eight 21-day-old male Wistar rats were obtained from the
Multidisciplinary Center for Biological Research (CEMIB),
University of Campinas. The animals were kept under normal
light conditions (12-h light:dark cycle) and received filtered tap
water and Purina rodent chow ad libitum.
On the 90th day after birth, the rats were divided in four groups
(n = 3) and assigned to different treatment groups. To cause
androgen deprivation, we utilized three different procedures with
different effects on epithelial cell apoptosis [21]. Animals in the
first group were castrated (Cas) by orchiectomy via scrotal incision
under ketamine (150 mg/Kg body weight) and xylazin (10 mg/kg
body weight) anesthesia. Animals in the second group received a
25 mg/Kg body weight dose of 17b-estradiol diluted in corn oil
(E2 group). The third group received a combination of both
treatments (Cas+E2 group) (combined orchiectomy and 17b-
estradiol). In the control group (Ct; normal androgen and
estrogen), the animals received only the vehicle. Three days after
the treatments, the rats were killed by anesthetic overdose, and the
ventral prostate was dissected out for the microarray and
immunohistochemistry analyses. For evaluation of the TF
expression after castration, 24 animals were distributed in eight
groups: one non-castrated (NC) and seven castrated (Cas) groups
(1 to 7 days after surgery).
The procedures were approved by the Committee for Ethics in
Use of Animals (CEUA) for the Institute of Biology, State
University of Campinas (protocol nos. 1945-1 and 3000-1).
RNA Extraction
Ventral prostates were dissected under RNAse-free conditions.
Thirty mg of the tissue was used for total RNA extraction.
Subsequently, the tissue fragments were extracted using Illustra
RNAspin Mini kits (GE Healthcare, Buckinghamshire, UK)
according to the manufacturer’s instructions. RNA purity was
analyzed by the ratio of absorbance at 260/280 nm (values higher
than 1.8) and by electrophoresis on 1.2% denaturing agarose gel.
The RNA concentration in each sample was determined in an
Ultrospec 2100 pro spectrophotometer (Amersham Biosciences,
Cambridge, England).
Microarray Hybridization
Whole transcript microarrays (Gene Chip Rat Gene 1.0 ST
Array) purchased from Affymetrix (Santa Clara, CA, USA) were
used for gene expression analysis. Microarray probes were
synthesized from 500 ng of total RNA using a WT Expression
kit (Ambion, Austin, TX, USA) according to the manufacturer’s
instructions. Single-strand cDNA was synthesized containing a T7
promoter sequence, and the second-strand cDNA was synthesized
by DNA polymerase in the presence of RNase H.
The antisense cRNA was synthesized and amplified by in vitro
transcription (IVT) of the second-strand cDNA template using
T7RNA polymerase. The cRNA obtained was purified to improve
the stability of the cRNA. From 10 mg of purified cRNA the sense-
strand cDNA (ss-cDNA) was synthesized by reverse transcription
using random primers, and the ss-cDNA contained dUTP at a
fixed ratio relative to dTTP. Then, the cRNA was degraded by
RNase H and the ss-cDNA was purified.
In the second part of the protocol, 5.5 ng of ss-cDNA in a
31.2 mL volume was nicked and labeled using the GeneChip WT
Terminal Labeling Kit (Affymetrix) according to the manufactur-
er’s instructions. The efficiency of the labeling procedure was
controlled by a protocol that prevents hybridizing poorly labeled
targets onto the probe array. The addition of biotin residues was
checked in a gel-shift assay using 4% agarose gel in TBE buffer
and monitoring for the presence of fragments with 200 bp or less.
For the hybridization, washing and staining steps, the
GeneChip Hybridization, Wash and Stain Kit (Affymetrix) was
used. 80 mL of the fragmented and labeled ss-cDNA solution was
loaded on the gene chip probe array and incubated at 45uC,
60 rpm for 18 h. The hybridized chip was set in the fluid station to
TF and the Prostate Response to Castration
PLOS ONE | www.plosone.org 2 June 2014 | Volume 9 | Issue 6 | e97080
stain and wash (GeneChip Fluidics Station 450; Affymetrix), and
scanned using the Affymetrix GeneChip Operating Software v1.3
program. The data were normalized and summarized by
Expression Console software (Affymetrix), and the results were
analyzed by bioinformatics.
Analysis of Microarray Results
The expression profile was evaluated for biological replicates
from the treatment and control groups. The summarized data
from microarray experiment were processed using bioconductor R
package (limma and affy libraries), the background correction was
done by using RMA (Robust Multi-array Average) and the
normalization was done by quantiles. The p-values were adjusted
by FDR multiple test correction. Probe to gene annotation was
done using the Affymetrix annotation files. Genes with fold-change
(Log2) .1.5 or , 21.5 and adjusted p-value ,0.01 were applied
for subsequent analyses. Genes appearing to be exclusive to or
shared (intersections) by the experimental groups were determined
using the script PERL, and shown as Venn diagrams.
The genes from microarray data (adjusted p-value ,0.01) were
also applied in Cytoscape software (BinGO plugin) to determine
the gene ontologies (GO). With this result, were considered all
significant enrichment terms using a hypergeometric test (FDR,
0.01) to obtain enrichment in Biological process (BP), Molecular
function (MF) and Cellular component (CC).
Transcription Factor and Transcription Regulators in the
Enrichment Terms
All genes present in BC, MF, CC, from enrichment terms
analysis, were used to construct regulatory networks using the
Ingenuity Pathway Analysis (IPA) software.
The transcription factors and transcription regulators enrolled
to construct the regulatory networks were identified and classified
as to whether or not they were differentially expressed in the
microarray data.
To test the correlation among these genes, androgen receptor
(Ar) and the estrogen receptors (Esr1 and Esr1), we constructed a
minimum spanning tree (MST) using the Pajek software. A
correlation matrix was prepared using the values of relative
expression for each gene extracted from the results published by
Su and co-workers [22]. The correlation distance matrix was




, where rij is the
correlation coefficient between list of variables i and j.
The standard variation of the values obtained for the relative
expression on the different tissues was used as vectors in the MST.
A detailed description of this procedure and their applications will
be published elsewhere.
TF Binding Sites in the Proximal Promoter Region of the
Most-regulated Genes
To find out more putative TF that can act in the prostate gland
after androgen deprivation, it was selected the 20 most regulated
genes (10-up and 10-down) exclusive to each treatment (Cas, E2
and Cas+E2) and shared by the three treatments according to fold-
change from microarray data. In total, 80 genes were analyzed
individually to determine putative TF binding sites in the 3,000 bp
upstream of the gene transcription start. To run this analysis the
selected sequences were loaded in the Match-1.0 program (www.
gene-regulation.com), and the parameters (a) vertebrate matrices
and (b) cutoff for the matrix of false-positive and false-negative
groups were selected to identify the TF binding sequences.
The resulting list was sorted according to the total number of
binding sites in the promoter regions. We also compared the
number of binding sites for the identified TF with those in the
proximal promoter region of the GAPDH and TBP-7 genes,
which were selected as internal controls, because their mRNA
levels were not affected by the treatments, as determined by qRT-
PCR.
The TF density (number of binding sites in the promoter region
divided by the number of genes) in the regulated genes was
compared with the TF density in the promoter region of the
internal control genes, as a way to eliminate those with a wide
distribution in the genome. Finally, we identified the TF that were
exclusive (or enriched) to each experimental group.
Figure 1 summarizes the combination of methodologies
employed in this study.
Quantitative Real-time PCR
Quantitative real-time PCR was used to determine the TF
expression at the mRNA level. We followed the kinetics of the
mRNA variation for up to seven days after castration. RNA
samples were reverse-transcribed to cDNA by a Super Script III
First-Strand Kit (Invitrogen, Carlsbad, CA, USA). cDNA was
mixed with TaqMan Universal PCR Master Mix (Applied
Biosystems, Foster City, CA) and inventoried assays
Rn01756649_g1 (Elk-1), Rn01493436_m1 (Evi-1),
Rn01750242_m1 (Mybl2), Rn01442895_m1 (Mybl1),
Rn01399583_m1 (Nfkb1), Rn01413842_g1 (Nfkb2),
Rn01502266_m1 (Rela), Rn00583735 (Gata2), Rn01648938_m1
(Nfyb) and Rn00573309_m1 (Hnf4a). For Rel(cRel), we designed the
primers FW: 59–CCGGCCGGACAGCTTT and Reverse: 59–
GCCAGCCCCGTCTAGGAA, and the probe: FAM-
CTCTAACTCACAAGGTGTCCT. Our attempts to produce
primers and probes for RelB produced no acceptable results, and
therefore the evaluation of this TF was limited to immunofluo-
rescence. The reactions were conducted and analyzed to
determine the threshold cycle in an Applied Biosystems 7300
Real-Time PCR System. The results are presented as fold-changes
calculated using the DDCt with the use of Gapdh (Rn01775763_g1)
as internal control, after testing 9 routinely used internal controls.
The statistical analyses included ANOVA and post hoc Tukey’s
test, considering the results as significant when p,0.05.
Immunofluorescence Analysis
The ventral prostates of control and castrated animals at day 3
after surgery were collected and immersed in Tissue-Tek O.C.T.
Compound (Torrance, CA, USA) and frozen in liquid nitrogen.
Five-mm cryosections were obtained and used for immunofluores-
cence. Sections were fixed first in cold methanol and then in 2%
paraformaldehyde for 10 min each. The sections were permeabi-
lized with 0.2% Tween 20 in PBS for 15 min at room
temperature. The autofluorescence was quenched with 10%
H2O2 in PBS for 15 min. Non-specific protein-protein interactions
were blocked by incubation with 10% pre-immune serum in PBS
for 1 h at room temperature.
The primary antibody against MYBL2 (goat, cat. ab53511) was
obtained from ABCAM (Cambridge, MA, USA). Antibodies
against EVI1 (rabbit, cat. 2593S), ELK1 (rabbit, cat. 9182S),
GATA2 (rabbit, cat. 4595S), NFKB1 p105/p50 (rabbit, cat.
3035S), NFKB2 p100/p52 (rabbit, cat. 4882S), NFKB p65/
RELA (rabbit, cat. 8242S), RELB (rabbit, cat. 4954S), and REL
(c-Rel) (rabbit, cat. 4774S) were obtained from Cell Signaling
(Beverly, MA, USA). They were diluted 1:300 in the 10% pre-
immune serum in PBS and incubated overnight at 4uC.
The tissue sections were rinsed three times in PBS and then
incubated with either Alexafluor 546-conjugated donkey anti-goat
Igs or goat-anti rabbit Igs (cat. A11056 and cat. A11010;
TF and the Prostate Response to Castration
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Invitrogen) secondary antibodies diluted 1:2000 in PBS for 1 h at
room temperature. After incubation in the secondary antibody,
the slides were washed in PBS and then incubated in DAPI for
10 min to stain the nuclei. Photo documentation and analysis were




Microarray analysis showed the gene expression profile of the
treated groups compared with the control animals. The criteria of
1.5-fold variation and a p,0.01 value were used to select the genes
with differential expression. This resulted in a total of 2,693 genes
that showed differential expression compared to the controls. One-
fifth (21.5%) of these genes (580 genes) were shared by the three
experimental conditions employed in this study (226 up and 354
down), as shown in the Venn diagrams in Figure 2. In addition to
sharing these differentially expressed genes, the Cas group showed
the largest number of differentially expressed genes (2,046 genes),
while the E2 group showed 830 genes, and only 132 exclusive
genes. The combined treatment (Cas+E2 group) showed an
intermediate number of differentially expressed genes (1,856 in
total) with 473 exclusive genes. It became clear that androgen
deprivation (Cas group) resulted in more exclusive genes that were
up-regulated than those that were down-regulated, suggesting that
the changes achieved by androgen deprivation require an active
process of gene expression to coordinate the modifications
associated with gland regression and tissue remodeling. In
contrast, more genes were down-regulated in response to the E2
treatment or the combination of Cas+E2. Thought.
TF in the Enrichment Terms
Enrichment terms were observed in the Cas (37 terms) and E2
(5 terms) groups, in the intersections between the three experi-
mental groups (common genes) (90 terms), and in the intersection
of the Cas and Cas+E2 groups (88 terms) (Fig. 3).
After the identification of the enrichment terms, we used the
IPA Ingenuity software to identify gene interaction networks.
Then, 135 transcription-regulation related candidates appearing
in those networks were isolated. Shown in Table S1 are the
candidates that were up- (40) or down-regulated (16) in the
microarray results. The analyses clearly showed that more TF
were up-regulated than down-regulated in each experimental
condition. This might reflect the predominance of the androgen-
regulated genes, and perhaps also the complexity of genes involved
in the squamous metaplasia transition induced by estrogen
stimulation (results not shown) [23].
We calculated the correlation among the expression of these
selected genes and that for the Ar, Esr1 and Esr2 in a series of
human tissues and opted to show the results as a MST, after
calculating the distances among the expression profiles. The
resulting MST is also shown in Figure 4. One obvious observation
is that genes differentially expressed in the microarray data have
different correlation with the Ar. TMF1 showed the highest
centrality in the tree. It was interesting to note that Ar, Esr1 and
Esr2 also occupied a relatively central position. The efficiency of
this construction in showing the correlation among the expression
pattern of different genes is manifested by the short distances
between the pairs Nkx3.1/Ar; Esr1/BRCA2, and Esr2/NFkB2,
because of well known functional associations among them.
Figure 1. Summary of the sequential analyses performed in this study.
doi:10.1371/journal.pone.0097080.g001
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TF in the Promoter Region of the 10 Most up- or down-
regulated Genes
From the microarray analysis, we selected the ten most up- or
down-regulated genes, as compared to the controls, that were
exclusive to each experimental group, and also those shared by the
three treatments (Table 1).
For each of these 80 genes, we did a search for transcription-
binding sites in the proximal 3,000-bp promoter region. The
density of the TF binding sites in the promoter was calculated by
dividing the number of binding sites by the number of genes
considered (i.e. 80 regulated genes and 2 controls) compared to
those found for the Gapdh and Tbp7 genes. These two genes were
chosen from a list of nine routinely used internal controls because
their expression did not vary in the different experimental groups,
as determined by qRT-PCR.
We found 55 putative TF binding sites that were absent from
the promoter region of the control genes Gapdh and Tbp7 (Fig. 5A).
Most of these TF binding sites were found in very low density.
Figure 5B shows the 61 TF binding sites found in the promoter
region of the regulated genes and in the promoter region of the
controls.
Finally, we compared the list of TF appearing in the gene
regulatory networks obtained with the use of Ingenuity (135
candidates) and those TF whose putative binding sites were found
in the proximal promoter of the 10 most-regulated genes that were
equal to or higher than in the promoter region of the non-
regulated genes (Gapdh and Tbp7) (84 candidates). Eight transcrip-
tion factors were present in both lists: EVI1, NFY, HNF4, ELK1,
GATA2, REL (c-Rel), MYB and NFkB. MYBL1 (A-MYB)
appeared up-regulated in the microarray data and was chosen
along with its family member MYBL2 (B-MYB) for further
analysis. Given the incompleteness of information about the
expression of NFkB family members in the prostate, we selected
different members for further validation. Unexpectedly and
perhaps fortuitously, this approach excluded important TF, such
as OCT1 [5], AR and estrogen receptors.
RT-PCR Validation of TF Expression
We validated the expression of the eight TF, their variants, and
some family members. Only the Hnf4 gene was not found to be
expressed in the adult prostate. The variation in expression of the
remaining seven TF was studied for up to seven days after
castration. We grouped them in three groups. Mybl1, Mybl2
(members of the MYB family) and Gata2 were grouped together
because of their known expression in immature hematopoietic cells
[24–26]. The second group included members of the NFkB
family: Nfkb1, Nfkb2, Rela and Rel (cRel). The third group included
the independent TF Evi1, Elk1 and Nfyb.
Mybl1 and Mybl2 showed statistically significant fold-increases
after castration (Fig. 6A and B). While the latter showed less
variation with a peak at day 3, the former increased as early as day
2. However, both genes increased only transiently. On the other
hand, Gata2 did not show significant variation in response to
castration (Fig. 6C), in agreement with a previous notion that this
gene is not affected by androgens, although it is known to
coordinate the expression of AR-regulated genes [5,27]. Direct
comparison of the trend line obtained by the fourth-order
polynomial (Fig. 6D) indicated that the oscillation in Gata2
expression, though not significant, appeared complementary to
Figure 2. Venn diagrams showing the number of genes that were differentially expressed. The diagrams show the genes that are
exclusive to each treatment and those that are shared by two or all three experimental groups (Cas, E2 and Cas+E2) compared to the control group.
doi:10.1371/journal.pone.0097080.g002
Figure 3. Number of enrichment terms exclusive or shared
among groups. The three treatments shared 90 enrichment terms.
The highest number of enrichment terms was found in the Cas group.
The Cas+E2 group showed no exclusive enrichment term.
doi:10.1371/journal.pone.0097080.g003
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Figure 4. Differentially expressed TF and transcription regulation-related genes. Transcription regulation-related genes indentified by the
IPA Ingenuity program and showing differential expression in those subgroups containing enrichment terms. Red and green colors highlight the up-
or down-regulated genes as compared with the control group, respectively. A minimum spanning tree is used to show the correlation among the
expression variation of the differentially expressed genes (yellow) plus the androgen receptor (AR) and estrogen receptors (ESR1 and ESR2) (red) in
human tissues. Each gene is indicated as a vertices and their size represent the standard deviation of their fold changes in different tissues. The edge
length is the distance calculated from the correlation matrix as explained in M&M. Of note, are the centrality of TMF1 and the short distances between
the pairs AR-NKX3-1, ESR1-BRCA2, and ESR2-NFKB2.
doi:10.1371/journal.pone.0097080.g004
Table 1. The eighty most regulated genes.
Groups Up-regulated Down-regulated
Cas Ska3/LOC689296/LOC681325 Aspn/RGD1562462/Slamf9 Ifit1/Kcnd2/Rnase2/Rpl21 Ocm/Furin/Isyna1 LOC287167/Aox3/Dmd/Slc17a9
Tomm7/Tnnt2/Hspb6
E2 Ankrd11/N5/Hamp/Sft2d1 LOC691979/nucleolin/Tns4 Slc39a1/Dync2h1/LOC290071 Sparc/Slc25a24/Susd2/Lcn2 Ly6c/Pi16/Glrx1/Kcnmb1
C1H6orf35/Tmem47
Cas+E2 Sh3rf2/LOC310926/Macc1/Chi3l1/Krt15/LOC259246 Rnase1l1/Sdr16c5/Obp3/Prol1 Mrpl41/Sms/Defb50/Hectd2 MGC109340/Scnn1g/Me1
V1rd15/Twf1/Pmp22
Shared RGD1565682/Cfh/Gnat2 Lrrc34/Mmp12/Gpnmb/Abcc3/V1rk2/Blnk/Mmp15 Ugt2b34/Cntn6/Cyp2c13 Oas1k/Neto2/Cpa6/Cdh12
Wfdc3/Lrrc37a/Ldoc1
The ten most up- or down-regulated genes that were exclusive to each of the experimental groups or were shared by the three treatments. These genes are involved in
different functions (see Appendix 1 for details on the annotated functions for these genes).
doi:10.1371/journal.pone.0097080.t001
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that shown by Mybl2. This form of representation also revealed
that Mybl1 expression precedes and extends longer than that of
Mybl2, and might be an inherent characteristic of their expression
that warrants further investigation.
Statistically significant increases in fold-change were observed
for Nfkb1 (Fig. 7A) and Nfkb2 (Fig. 7B) after castration, but not for
Rel (cRel) (Fig. 7C) and Rela (Fig. 7D). Nfkb1 and Nfkb2 expression
appeared transient, with peaks at days 4–5. Using the same direct
comparison of the trend lines for the four genes together (Fig. 7E),
and examining the non-significant variation measured for the Rel
and Rela, we noted that Rel differed from the others in showing
incremental increases within the timeline of the experiments, while
the variation in the others seemed to be transitory. We speculate
that the transient nature of gene expression observed for three of
the NFKB members might be connected to transitory events in the
adjustment of the castration-resistant cells to the androgen-
deprived condition.
The quantification of Evi-1 expression in response to castration
revealed no significant variation (Fig. 8A). In contrast, the
quantification of Elk-1 revealed not only a significantly increased
expression, but also an interesting pattern, remaining steady for up
to day 3 and then increasing up to 3-fold, before returning to the
level of the control (Fig. 8B). Nfyb quantification and kinetics were
equally interesting (Fig. 8C). Although a significant increase was
only found at day 5, it showed a long lasting slight increase in
mRNA content. Superimposing the trend lines (Fig. 8D) of these
three apparently independent TFs provided no further elucidation
of a stereotyped behavior, except for reinforcing the delayed
increase in Elk-1 expression after castration.
Immunofluorescence Localization of the Newly Identified
TF
The immunofluorescence revealed that the selected TF were
differentially distributed in the epithelial and stromal cells of the
rat ventral prostate (Fig. 9). Several TF are present in both
epithelial and stromal cells, but had unique distributions (Fig. 9).
We found MYBL2 to be concentrated in the epithelial cells and
discretely in the cell nucleus. GATA2, on the other hand, was
found in both epithelial and stromal cells, with clear nuclear
localization in non-castrated animals. The number of cells showing
nuclear localization was reduced in animals examined 3 days after
castration.
EVI1 was found in both epithelium and stroma, and showed
nuclear localization in the epithelium after castration. ELK1
showed a restricted stromal localization in morphologically
recognized smooth-muscle cells. NFYB was detected in the
nucleus of epithelial cells in non-castrated animals. The nuclear
localization was partly lost after castration. Stromal cells were also
positive for NFYB.
NFkB1 was found in both epithelium and stroma in non-
castrated and castrated animals. The epithelium also expressed
RelA and RelB, which, similarly to NFkB1, were not responsive to
castration in terms of epithelial/stromal distribution. In contrast,
REL was expressed in the epithelium after castration and was
found in the cell nucleus. Since nuclear translocation of this (and
other family members) occurs upon activation [28], this location is
a good indication that REL is activated after castration. NFkB2
and REL were found exclusively in stromal cells, and maintained
this distribution after castration. In contrast, the expression of
RelB in the stroma was suppressed in response to androgen
deprivation. Figure S1 summarizes these findings.
Discussion
By comparing the gene expression profiles in the prostate under
different hormonal conditions (androgen deprivation, high dose of
17b-estradiol, and a combination of these), we identified seven TF
(and some variants), which were further characterized with respect
to their expression in the prostate and possible variations in
response to castration. These TF were found to be differentially
expressed and were grouped in three functionally important
groups: (i) coordinators of the immaturity state or regulators of
Figure 5. TF with possible binding sites found in the 80 most-regulated genes. (A) TF binding sites not found in the internal control genes.
(B) TF binding sites also found in the proximal promoter of internal control genes. Density values#0.01 were omitted.
doi:10.1371/journal.pone.0097080.g005
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epithelial differentiation (MYBL1/MYBL2 and GATA-2), (ii)
coordinators of the ability of the organ to function as an immune
barrier (NFkB family members), or (iii) early-response genes or
genes related to the response to extracellular signaling (EVI1,
ELK1 and NFYB), which together coordinate the epithelial and/
or stromal cell behavior under androgen-deprived conditions.
It is well understood that treatment with androgens increases
the AR and coactivator occupancy in the PSA enhancer and
promoter regions [29–33]. Although the regulation of genes such
as PSA by the AR in prostate cells seems to be relatively simple,
and the prostate weight loss after castration is a direct effect,
complex mechanisms are involved in the adaptation of the gland
to varying levels of androgen stimulation.
We considered that extracting information from the mass of
genes revealed by the present experiments using the usual tools
could be misleading, in the sense that some regulatory molecules
might show subtle or no variations in mRNA content and might
escape detection in assays of differential expression. Therefore, we
defined an experimental approach to filter for druggable TF that
could function as state-defining regulatory hubs by orchestrating
different functions related to tissue remodeling and as regulators of
differentiation, among others, and localizing these TF to either the
epithelium and/or the stroma, and employed a MST to determine
the correlation among their expression levels is a number of
tissues.
Figure 6. Kinetics of Mybl1, Mybl2 and Gata2 expression. Quantitative RT-PCR determination of the mRNA content for the Mybl1 (A), Mybl2 (B)
and Gata2 (C) genes in the prostate of non-castrated (NC) and castrated rats up to 7 days after surgery. The fold-change variation with respect to the
controls is shown as the mean 6 the standard variation (n = 3 for each time point). The asterisks indicate p,0.05. The dotted lines in each figure
correspond to the fourth-power exponential fitting curve, and are shown together for the sake of direct comparison in D.
doi:10.1371/journal.pone.0097080.g006
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We identified TF genes in regulatory networks established from
the enrichment terms and from the analysis of the proximal
promoter region of the genes that were regulated by androgen
deprivation, as revealed by the microarray analysis and referenced
not only to the normal androgen levels in non-castrated rats, but
also to the high-dose estrogen stimulus.
The search for biological relationship between the TF found in
the selected networks and the steroid hormone receptors Ar, Esr1
and Esr2 was unveiled by calculating their expression correlation
(and the resulting distance matrix) and constructing a MST. One
obvious observation is that genes differentially expressed in the
microarray data have different correlation with the Ar. One
surprising finding was the high centrality of TMF1, named after
TATA element modulatory factor [34], and later characterized as
the first androgen receptor coactivator [35]. This factor was later
characterized as a golgin and found in both nuclear and cytosolic
factors [36,37]. This dual localization and functional properties is
intriguing and will certainly deserve further research. The MST
also demonstrated that Ar, Esr1 and Esr2 also occupied a relatively
central position. Nonetheless, the efficiency of this construction in
showing the correlation among the expression pattern of different
genes is manifested by the short distances between the pairs
Nkx3.1/Ar; Esr1/BRCA2, and Esr2/NFkB2, because of well
known functional associations among them.
Comparison of these TF with those whose putative binding sites
in the promoter regions of the regulated genes uncovered a list of
interesting candidates: EVI1 (Mecom), NFY, HNF4alpha, ELK1,
GATA2, MYB, REL and NFkB. These eight transcription factors
by the in silico analyses were validated, and only HNF-4 was found
not expressed in the prostate (positive PCR and immunohisto-
chemistry in the liver, used as positive control; data not shown).
MYBL1, MYBL2 and GATA-2 Define Lineage Commitment
and the Immaturity State of Epithelial Cells
The genes Mybl1 and Mybl2 belong to the MYB family, along
with c-MYB. Both of them showed significantly enhanced
expression under androgen deprivation. Besides, these TF have
multiple binding sites in the promoter region of the regulated
genes, and were found in enrichment gene networks in the Cas
and Cas+E2 (data not shown).
MYBL2 is related to proliferative activity. Use of the MMTV-
PyMT mouse was instrumental in the discovery that Myb is
essential for the development of mammary tumors, but not
ultimately for their progression [38]. In vitro tests showed that
normal mammary epithelial NMuMG cells transduced with Myb
show high proliferation and reduced apoptosis [39], consistent
with Myb activation during the S through G2/M phases of the cell
division cycle [40–42]. MYBL2 was reported to be associated with
the control of expression of the anti-apoptotic protein bcl-2, by
physically interacting with the promoter of this gene [43].
Recently, the functional aspects of Myb expression were
investigated in LNCaP and its derivative C4-2 cells after super-
expression or knockdown experiments [44], after the realization
that Myb is frequently amplified in CRPC [45]. The authors
provided solid evidence that Myb affects proliferation, adhesion,
anchorage dependency, and several epithelial to mesenchymal
transitions (EMT), and proposed that Myb is closely associated
with disease progression [44].
It remains to be determined what the direct targets of MYBL1
and MYBL2 in the prostate gland are, and how these transcription
factors interact with AR in the response to variations in androgen
levels.
Figure 7. Kinetics of Nfkb1, Nfkb2, Rel and RelA expression. Quantitative RT-PCR determination of the mRNA content for the Nfkb1 (A), Nfkb2
(B), Rel (c-Rel) (C) and RelA (D) genes in the prostate of non-castrated (NC) and castrated rats up to 7 days after surgery. The fold-change variation with
respect to the controls is shown as the mean 6 standard variation (n = 3 for each time point). The asterisks indicate p,0.05. The dotted lines in each
figure correspond to the fourth-power exponential fitting curve, and are shown together for the sake of direct comparison in E.
doi:10.1371/journal.pone.0097080.g007
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On the other hand, GATA-2 has more-evident effects on
prostate cancer cells. GATA-2 and Oct-1 were found to be
sequentially recruited to the enhancer region of AR-regulated
genes [5]. Nonetheless, GATA-2 was further characterized as a
factor in high risk of recurrence, PSA recurrence, and metastatic
progression. Notably, the high expression was not associated with
any detectable mutation in GATA-2 in these tumors [27]. The
authors also demonstrated that GATA-2 regulates KLK2, but not
AZGP1, two genes that are directly regulated by AR.
One study has demonstrated that GATA-2 is necessary for non-
small cell lung cancer, via regulation of the proteasome, IL-1/
NFkB signaling and Rho-signaling pathways, thereby providing
enhanced proliferation for RAS-mutation. The authors suggested
that GATA-2 operates orthogonally to oncogenes, as it is not
directly affected by the receptor tyrosine kinase/RAS pathway,
and that the GATA-2-centered network could represent a stress-
response mechanism. In line with this evidence, our results
revealed no significant variation in Gata2 expression after
castration (Fig. 6C), indicating a relative independence from AR
signaling. Finally, the presence of GATA2 in the cell nucleus (Fig. 9
and Fig. S1) indicates that GATA-2 is found in its active form.
To our knowledge, this is the first demonstration that MYBL1/
MYBL2 and GATA-2 are expressed and likely involved in
modulating the response to androgen deprivation in physiological,
non-tumor conditions in prostate epithelial cells.
We are convinced that the immaturity state coordinated by
MYB1/2 and GATA2 is a hallmark of epithelial cells that
facilitates the transition to CRPC in humans and represent targets
for a therapeutic approach to this devastating disease.
NFkB Family Members Integrate the Epithelial and
Stromal Functions as an Immune Barrier
Immune-system cells are found in the prostate, and are present
in larger numbers after castration. Mast cells are readily identified
Figure 8. Kinetics of Evi1, Elk1 and Nfyb expression. Quantitative RT-PCR determination of the mRNA content for the Evi1 (A), Elk1 (B) and Nfyb
(C) genes in the prostate of non-castrated (NC) and castrated rats up to 7 days after surgery. The fold-change variation with respect to the controls is
shown as the mean 6 standard variation (n = 3 for each time point). The asterisks indicate p,0.05. The dotted lines in each figure correspond to the
fourth-power exponential fitting curve, and are shown together for the sake of direct comparison in D.
doi:10.1371/journal.pone.0097080.g008
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by their characteristic morphology, and macrophages and
lymphocytes have been reported by others [15]. It is also known
that androgens regulate a specific immune/inflammatory response
[15,19], but in transcriptome analysis, the presence of immune
cells influences or obscures the contribution of immune-response
genes.
The combined strategy employed in this study allowed us to
identify c-Rel and NFkB TF among those selected by bioinfor-
matics, and to extend their characterization to other family
members. The variations in gene expression and location in the
epithelial and/or stromal compartments, in particular the
appearance of REL in the epithelium and the disappearance of
RelB expression in the stroma in response to castration, suggest a
dynamic adaptation of these important TF to the absence of
androgen stimulation, in particular the possible dimers that they
can form, particularly after the silencing of the secretory function,
Figure 9. TF localization in epithelial and stroma cells. Immunohistochemical localization of selected TF (red) as indicated in the prostate of
non-castrated controls (NC) and castrated rats 3 days after surgery (CAS). MYBL2 (A,B), GATA2 (C,D), EVI1 (E,F), ELK1 (G,H), NFYB (I,J), NFKB1 (K,L),
NFKB2 (M,N), REL (O,P), RELA (Q,R), RELB (S,T). Nuclei were stained with DAPI (blue). White arrows indicate smooth-muscle cells. Yellow arrowheads
indicate cells showing nuclear location of the TF. L = gland lumen; S = stroma. Scale bars = 50 mm.
doi:10.1371/journal.pone.0097080.g009
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the major role of the gland. Furthermore, the nuclear location of
REL suggests that it is present in the active form and it may have a
role in non-pathogen-induced functions of members of the NFkB,
such as a blocker of apoptosis [46], and in the possible survival of
epithelial cells in the androgen-poor environment.
Maldonado and collaborators have characterized the capacity
of prostate stromal cells to recognize and respond to pathogen-
associated molecular patterns (PAMPs), given the characteristic
pattern of Toll-like receptor 4 (TLR4) expression [47]. They also
extended the observations to determine the effects of castration,
and showed that RELA (therein referred to as NFkB/p65), in
combination with CD14 and MyD88, coordinates the adaptation
of epithelial and smooth-muscle cells to androgen deprivation,
including the ability to produce surfactant protein D (SP-D)
[48,49].
The results reported here are in good agreement with these
functional assays. They add an extra layer to the mechanisms
regulating the ability of the prostate to deal with infectious agents,
and reinforce the notion that the epithelium and stroma perform
complementary and perhaps overlapping functions as an immune
barrier. It will be interesting to determine how these functions
correlate with the gland function to produce and secrete anti-
inflammatory factors, as well as their variations and function in
human prostatitis.
Nonetheless, we suggest that the combined functions of these
TF regulate the recruitment of immune cells to the organ and also
the functioning of these immune cells, including the ability to
concentrate immunoglobulins (mostly IgA and IgG) in the
secretion.
Immediate Early-response Genes and NFYB
The EVI1 (Mecom) function was found to overlap with the FOS
early-response gene [50]. Elk-1 is among the TCF factors that
regulate the cell response to extracellular signals, and is a direct
target of MAP kinase/ERK1 phosphorylation to control the
expression of c-fos [51,52]. ELK-1 distribution was restricted to
the smooth-muscle cells and showed increased expression after
four days under androgen deprivation, while EVI1 and NFYB
were found in both the epithelium and the stroma, and were
irresponsive to androgen. This is compatible with the changes in
these cells in the first week after castration, most obviously a
reduction in cell volume [53], and with a reported involvement
with the reorganization of collagen fibers in the extracellular
matrix [54]. ELK1, Serum Response Factor (SRF) and NFkB
(NFKB1/p50 and RELA/p65) show increased expression in the
response of vascular smooth-muscle cells to oxidative stress caused
by hemin [55]. Yeh et al. (2009) found that increased expression of
ELK1 with increased tumor grading in prostate cancer and NFYB
are among the regulatory networks that differ in cancer cells as
compared to normal tissue [20]. However, direct regulation of
ELK1 by the AR [56] and estrogen-receptor [57] pathways has
been suggested.
NFYB forms ternary complexes with NFYA and NFYC. NFYB
shows interaction with p53, with significant overlapping target
genes in HCT116 cells [58], with emphasis on ER-stress regulators
and regulators of p53 itself. Notably, NFYB interacts with p53 to
downregulate Chk2, which is associated with DNA damage-
induced cell cycle progression in G2, and specifically targets cdc25
and p53 [59], and p73 to block the PDGFB receptor [60]. It will
be interesting to investigate how NFY is involved in the reported
dissociation of p53 and apoptosis in prostate regression after
castration [61].
Taken together, the present data reveal novel TF that may
contribute not only to prostate carcinogenesis and progression to
CRPC, but also to the regulation of gene expression during the
physiological adjustment of this organ to androgen variations in
seasonal reproducers or in social groups with a male hierarchy.
Supporting Information
Figure S1 TF localization in epithelial and stroma cells.
Schematic drawing showing the distribution of the newly identified
TF in the epithelium and stromal cells of the rat ventral prostate,
as observed by immunohistochemistry, and their variations in
response to castration at day 3 after surgery.
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